These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7913769)

  • 1. [Anesthetic management with propofol in a case of porphyria cutanea tarda].
    García-Galán F; Pensado A; Luengo A; Roca E; Cabrero Y
    Rev Esp Anestesiol Reanim; 1994; 41(2):124-5. PubMed ID: 7913769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anesthesia with propofol and atracurium in a case of porphyria cutanea tarda].
    Baratto F; Meggiolaro M
    Minerva Anestesiol; 1998 Nov; 64(11):535-9. PubMed ID: 9951273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyrin metabolism abnormalities and its treatment in a uremic patient with porphyria cutanea tarda.
    Yasuda G; Ikeda Y; Satta H; Shionoiri H; Ishii M; Ikezawa Y
    Nephron; 1993; 63(2):235-6. PubMed ID: 8095699
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of myocardial infarct in latent porphyria cutanea tarda].
    Krivosheev AB
    Ter Arkh; 1997; 69(4):80-1. PubMed ID: 9213971
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of chloroquine treatment of porphyria cutanea tarda on the associated liver disease].
    Wolff Fernández C; Krause Ianpaglia P; Franco Silva C; Armas Merino R
    Rev Invest Clin; 2000; 52(2):211-3. PubMed ID: 10846447
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary porphyrin concentration in porphyria cutanea tarda.
    Moran MJ; Santos JL; Fontanellas A; Sepulveda P; Enriquez de Salamanca R
    J Dermatol Sci; 1993 Oct; 6(2):155-8. PubMed ID: 7903863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda.
    Blauvelt A
    Arch Dermatol; 1996 Dec; 132(12):1503-4. PubMed ID: 8961882
    [No Abstract]   [Full Text] [Related]  

  • 11. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of a systemic lupus erythematosus and porphyria cutanea tarda: case successfully improved by avoidance of sun exposure.
    Murata J; Shimizu T; Tateishi Y; Abe R; Shimizu H
    Int J Dermatol; 2006 Apr; 45(4):435-7. PubMed ID: 16650173
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alcohol and its effect on porphyrin metabolism].
    Krivosheev BN; Krivosheev AB
    Ter Arkh; 1994; 66(2):32-6. PubMed ID: 7909174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection with hepatitis C virus in porphyria cutanea tarda].
    Lima J; Serejo F; Gloria H; Ramalho F; Moura MC
    Acta Med Port; 1996; 9(7-9):283-6. PubMed ID: 9005712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
    Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
    Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda complicating transfusion-dependent myelodysplastic syndrome.
    Goulding JM; Purohit G; Borg A; Rose P; Gee BC
    Br J Haematol; 2007 Jan; 136(1):2. PubMed ID: 17222194
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-classical congenital adrenal hyperplasia in association with porphyria cutanea tarda: co-incidence or trigger?
    Ramaswamy M; Ead R; Buckler H; Houghton J; Stewart MF
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):500-2. PubMed ID: 22783026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyria cutanea tarda.
    Khoo BP; Tay YK
    Singapore Med J; 2000 Jun; 41(6):292-4. PubMed ID: 11109347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
    Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.